US Broker Ratings

Haleon plc (HLN): Analyst Ratings Signal 30% Upside Potential for Investors

Haleon plc (NYSE: HLN), a titan in the consumer healthcare sector, is catching investor attention with a promising outlook. With a market capitalization of $39.55 billion, Haleon operates at the..

Alnylam Pharmaceuticals (ALNY) Investor Outlook: A Biotech Leader with 56.90% Upside Potential

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands as a beacon of innovation in the biotechnology sector, leveraging its robust pipeline of RNA interference-based therapeutics to address unmet medical needs. This Massachusetts-based..

Labcorp Holdings Inc. (LH) Stock Report: Analyst Consensus Points to a 21% Upside Potential

Labcorp Holdings Inc. (NYSE: LH), a prominent player in the healthcare sector specializing in diagnostics and research, is attracting attention from investors thanks to its robust market position and promising..

Fresenius Medical Care AG (FMS) Stock Analysis: Navigating Challenges with a Promising Dividend Yield

Fresenius Medical Care AG (NYSE: FMS), a stalwart in the healthcare sector, provides a crucial service in the medical care facilities industry. With a market cap of $12.67 billion, this..

Revvity, Inc. (RVTY) Stock Analysis: Navigating a 13.64% Upside Potential in the Diagnostics & Research Sector

Revvity, Inc. (RVTY), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, is drawing investor attention with a compelling 13.64% potential upside. Headquartered in Waltham,..

Edwards Lifesciences Corporation (EW) Stock Analysis: Navigating a 10.95% Potential Upside in the Medical Devices Sector

Edwards Lifesciences Corporation (NYSE: EW) stands as a formidable player in the healthcare sector, specifically within the niche of medical devices. With a market capitalization of $50.3 billion, this Irvine,..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating the Healthcare Plans Landscape with a 4.48% ROE

In the intricate world of healthcare plans, Molina Healthcare Inc (NYSE: MOH) stands as a significant player with a market capitalization of $10.18 billion. Headquartered in Long Beach, California, Molina..

Becton, Dickinson and Company (BDX) Stock Analysis: Is a 25.5% Potential Upside Within Reach?

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, is drawing investor attention with its potential upside of 25.5%, based on its average target price of $180.69...

Insmed Incorporated (INSM) Stock Analysis: Exploring a 105.79% Potential Upside in the Biotech Sector

Investors looking for opportunities in the biotechnology sector may find Insmed Incorporated (NASDAQ: INSM) an intriguing candidate. With a market capitalization of $20.76 billion, Insmed operates from its headquarters in..

Boston Scientific Corporation (BSX) Stock Analysis: Potential 68.87% Upside with Strong Buy Ratings

Boston Scientific Corporation (NYSE: BSX), a renowned player in the healthcare sector specializing in medical devices, is capturing the attention of investors with a remarkable potential upside of 68.87%. With..

Moderna, Inc. (MRNA) Stock Analysis: Navigating a 260% Revenue Growth Amidst a Challenging Valuation Landscape

Investors looking into Moderna, Inc. (MRNA), a key player in the biotechnology industry, are faced with a complex evaluation of its current financial metrics and market position. Known for its..

Veeva Systems Inc. (VEEV) Stock Analysis: Unlocking Over 60% Potential Upside with Strong Analyst Support

For investors seeking robust opportunities in the healthcare technology sector, Veeva Systems Inc. (NYSE: VEEV) offers a compelling proposition. With a market capitalization of $24.9 billion, Veeva is a major..

Genmab A/S (GMAB) Stock Analysis: Biotechnology Giant Displays 45.7% Potential Upside

For investors keen on exploring opportunities in the healthcare sector, Genmab A/S (NASDAQ: GMAB) stands out as a compelling candidate. With a robust 45.7% potential upside, this Denmark-based biotechnology leader..

Exelixis, Inc. (EXEL) Stock Analysis: Evaluating Growth Prospects and Market Position in the Biotech Sector

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, has become a focal point for investors interested in the healthcare industry. With a market capitalization of $13.05 billion,..

Koninklijke Philips N.V. (PHG) Stock Analysis: Navigating a 25% Potential Upside in Healthcare Innovation

In the dynamic world of healthcare technology, Koninklijke Philips N.V. (NYSE: PHG) stands out as a formidable player with a significant footprint. With its headquarters in Amsterdam, this Dutch multinational..

Insulet Corporation (PODD) Stock Analysis: A Strong Buy with 66% Upside Potential

Investors seeking opportunities in the healthcare sector may find Insulet Corporation (NASDAQ: PODD) to be an enticing prospect. The company, which specializes in innovative insulin delivery systems, has generated considerable..

Smith & Nephew SNATS, Inc. (SNN): Navigating Growth in the Medical Devices Sector with a 16.33% Potential Upside

Smith & Nephew SNATS, Inc. (NYSE: SNN) stands as a formidable entity in the healthcare sector, specifically within the medical devices industry. With a significant market capitalization of $12.72 billion,..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Unveiling a 29.44% Potential Upside for Investors

In the ever-evolving landscape of healthcare technology, GE HealthCare Technologies Inc. (NYSE: GEHC) stands as a significant player, particularly in the medical devices industry. With a market capitalization of $28.02..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: A 26% Upside with Robust Revenue Growth

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the healthcare sector, specializes in diagnostics and research, primarily focusing on veterinary, livestock, and water quality testing. With a substantial market..

Royalty Pharma plc (RPRX) Stock Analysis: Exploring an 11.88% Potential Upside with Strong Buy Ratings

Royalty Pharma plc (NASDAQ: RPRX) stands as a distinctive player in the biotechnology industry, offering investors a unique opportunity to engage with the healthcare sector. Based in New York, this..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds